“Bimekizumab in Patients With Moderate to Severe Plaque Psoriasis by Bodyweight: Pooled Results from Phase 3 Trials”. SKIN The Journal of Cutaneous Medicine, vol. 6, no. 6, Nov. 2022, p. s73, https://doi.org/10.25251/skin.6.supp.73.